Altered body composition and increased visceral adipose tissue in premenopausal and late postmenopausal patients with SLE

[1]  L. Chow,et al.  DXA-Determined Regional Adiposity Relates to Insulin Resistance in a Young Adult Population with Overweight andObesity. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[2]  P. Sfikakis,et al.  Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity , 2018, Rheumatology.

[3]  A. Atta,et al.  Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus , 2018, Clinical Rheumatology.

[4]  E. Bonfá,et al.  Increased visceral adipose tissue and altered adiposity distribution in premenopausal lupus patients: correlation with cardiovascular risk factors , 2018, Lupus.

[5]  C. Fall,et al.  Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk , 2017, International Journal of Obesity.

[6]  C. Torp-Pedersen,et al.  The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study , 2017, Rheumatology.

[7]  T. Kivisild,et al.  Validity of visceral adiposity estimates from DXA against MRI in Kuwaiti men and women , 2017, Nutrition & diabetes.

[8]  R. Hoermann,et al.  Correlation of visceral adipose tissue measured by Lunar Prodigy dual X-ray absorptiometry with MRI and CT in older men , 2016, International Journal of Obesity.

[9]  D. Gladman,et al.  Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review , 2016, The Journal of Rheumatology.

[10]  L. Punzi,et al.  Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review , 2015, Expert opinion on drug safety.

[11]  B. Goodpaster,et al.  Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women. , 2013, Atherosclerosis.

[12]  S. Lekamwasam,et al.  Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry , 2013, Lupus.

[13]  E. Baracat,et al.  Physiotherapeutic approach in early and late post-menopausal Brazilian women , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[14]  S. Lear,et al.  A Cross-Sectional Analysis of the Association between Physical Activity and Visceral Adipose Tissue Accumulation in a Multiethnic Cohort , 2012, Journal of obesity.

[15]  E. Borba,et al.  Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect , 2012, Lupus.

[16]  P. Sluss,et al.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging , 2012, Menopause.

[17]  Xue-Qing Yu,et al.  Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus , 2012, Clinical Rheumatology.

[18]  Y. Wang,et al.  Prevalence and correlation of conventional and lupus‐specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  C. Mok,et al.  Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. , 2011, Arthritis and rheumatism.

[20]  J. Fonseca,et al.  Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. , 2011, Clinical and experimental rheumatology.

[21]  A. González-Chávez,et al.  Relación triglicéridos/colesterol-HDL elevada y resistencia a la insulina , 2011 .

[22]  M. Szklo,et al.  Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. , 2010, Arthritis and rheumatism.

[23]  H. Sasai,et al.  The effects of vigorous physical activity on intra-abdominal fat levels: a preliminary study of middle-aged Japanese men. , 2010, Diabetes research and clinical practice.

[24]  R. Vasan,et al.  Association of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity , 2009, Diabetes Care.

[25]  E. Barrett,et al.  Effect of exercise training intensity on abdominal visceral fat and body composition. , 2008, Medicine and science in sports and exercise.

[26]  B. Tom,et al.  Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[27]  C. Mok,et al.  Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus , 2008, Lupus.

[28]  A. Karelis,et al.  Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[29]  S. Lear,et al.  Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). , 2007, The American journal of clinical nutrition.

[30]  Daniel McConnell,et al.  Hormone predictors of bone mineral density changes during the menopausal transition. , 2006, The Journal of clinical endocrinology and metabolism.

[31]  W. Kraus,et al.  Inactivity, Exercise, and Visceral Fat. STRRIDE: A Randomized, Controlled Study of Exercise Intensity and Amount. , 2005, Journal of applied physiology.

[32]  D. Giannella‐Neto,et al.  Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[33]  M. Abrahamowicz,et al.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[34]  B. Wajchenberg.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[35]  P. Wahl,et al.  Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. , 1999, Diabetes care.

[36]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[37]  C. Russell,et al.  Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. , 1993, The Journal of clinical investigation.

[38]  O. Nived,et al.  Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population , 1989, Medicine.

[39]  A. González-Chávez,et al.  Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance. , 2011, Cirugia y cirujanos.

[40]  M. Sowers,et al.  The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN , 2003, Osteoporosis International.

[41]  L. Pallardo,et al.  Vascular Health and Risk Management Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention , 2022 .